Trailing-twelve-month (TTM) revenue is $450,000 with a year-over-year growth of +90.68%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $50,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $97,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-18 |
| Q1 FY2026Period ended 2026-03-31 | $101,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $202,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $450,000 |
Current P/S: $51,177,855 market capitalization ÷ $450,000 TTM revenue = 113.73x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:45:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $202000.00.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:47:38.296Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Product | $1M | $2M | $477,000 | $97,000 | $157,000 |
| Technology Service | $2M | $2M | $987,000 | $105,000 | $76,000 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Asia | $145,000 | $256,000 | N/A | N/A | $23,000 |
| Asia Pacific | N/A | N/A | $57,000 | N/A | N/A |
$450,000
$450,000
+90.68%
vs. $235,997.483 a year ago (TTM)
(28.99%)
5 Year compound annual growth rate
1 Year
+90.68%
3 Year
(47.24%)
5 Year
(28.99%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $233,000 | +$31,000 | +15.35% |
| 2024 | $202,000 | ($1.26M) | (86.20%) |
| 2023 | $1.46M | ($2.18M) | (59.86%) |
| 2022 | $3.65M | +$640,000 | +21.28% |
| 2021 | $3.01M | +$1.43M | +90.44% |
TTM Growth
+90.68%
3-Year CAGR
(47.24%)
5-Year CAGR
(28.99%)
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:47:38.296Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Europe |
|---|
| N/A |
| N/A |
| $184,000 |
| $48,000 |
| $93,000 |
| Europe, Excluding Germany | $111,000 | $855,000 | N/A | N/A | N/A |
|---|
| GERMANY | $536,000 | $65,000 | N/A | N/A | N/A |
|---|
| UNITED STATES | $2M | $2M | $1M | $154,000 | $117,000 |
|---|
